Skip to content

Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction

Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction - the INDUCT Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05940649
Acronym
INDUCT
Enrollment
262
Registered
2023-07-11
Start date
2023-07-03
Completion date
2024-07-01
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Hypotension

Brief summary

Intraoperative hypotension is common in patients having non-cardiac surgery with general anesthesia and is associated with organ injury and death. The timely treatment of intraoperative hypotension is thus important to avoid postoperative complications. About one third of intraoperative hypotension occurs during anesthetic induction - i.e., between the start of anesthetic induction and surgical incision. Hypotension during anesthetic induction is associated with postoperative acute kidney injury. Unmodifiable risk factors for hypotension during anesthetic induction include age, male sex, and a high American Society of Anesthesiologists physical status class. However, hypotension during anesthetic induction is mainly driven by modifiable factors - specifically, anesthetic drugs that cause vasodilation. In most German hospitals, norepinephrine is the first-line vasopressor to treat hypotension during anesthetic induction. Norepinephrine is usually given as repeated manual boluses of 5, 10, or 20 μg. The continuous administration of norepinephrine via a perfusion pump is usually started only later. It remains unknown whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction. We thus propose to investigate whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction in non-cardiac surgery patients.

Interventions

In patients randomized to continuous norepinephrine administration, hypotension (= mean arterial pressure \< 65mmHg) will be treated with continuous norepinephrine infusion. The norepinephrine perfusion line will be connected to the saline infusion line using a three-way valve. Treating anesthesiologists will be free to reduce or increase the norepinephrine infusion rate anytime.

Sponsors

Kristen Thomsen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* non-cardiac surgery * \>45 years of age * American Society of Anesthesiologists physical status classification II, III, and IV.

Exclusion criteria

* Planned intraarterial blood pressure monitoring during anesthetic induction with an arterial catheter * Emergency surgery * Transplant surgery * History of organ transplant * Pregnancy * Heart rhythms other than sinus rhythm * Impossible Finger-cuff blood pressure monitoring * Rapid sequence induction

Design outcomes

Primary

MeasureTime frameDescription
Hypotension during anesthetic inductionFirst 15 minutes of anesthetic inductionArea under a MAP of 65 mmHg \[mmHg x min\]

Secondary

MeasureTime frameDescription
Hypertension during anesthetic inductionFirst 15 minutes of anesthetic inductionDuration of a MAP \>100, \>110, \>120, and \>140 mmHg \[min\]
Hypotension during anesthetic inductionFirst 15 minutes of anesthetic inductionArea under a MAP of 60, 50, and 40 mmHg \[mmHg x min\]

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026